LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
15.04
-0.97 (-6.06%)
At close: Oct 8, 2025, 4:00 PM EDT
15.04
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:10 PM EDT

LB Pharmaceuticals Stock Forecast

Stock Price Forecast

The 3 analysts that cover LB Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $46.33, which forecasts a 208.05% increase in the stock price over the next year. The lowest target is $27 and the highest is $78.

Price Target: $46.33 (+208.05%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$27$46.33$34$78
Change+79.52%+208.05%+126.06%+418.62%

Analyst Ratings

The average analyst rating for LB Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingOct '25
Strong Buy1
Buy2
Hold0
Sell0
Strong Sell0
Total3

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Initiates
$78
BuyInitiates$78+418.62%Oct 6, 2025
Stifel
Stifel
Strong Buy
Initiates
$27
Strong BuyInitiates$27+79.52%Oct 6, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$34
BuyInitiates$34+126.06%Oct 6, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.